Interpace Biosciences IDXG
OTC IDXG
$6.05 -0.20 (-3.20%)
At close: Nov 13, 2026 · 4:00 PM EST

Interpace Biosciences (IDXG) Return on Sales [ROS] (2009 - 2026)

Updated

Interpace Biosciences' Return on Sales [ROS] was 3.52% in Q2 2026, up 8.58 percentage points from -5.07% a year earlier but down 8.92 percentage points from the prior quarter.

Analysis

Interpace Biosciences (IDXG) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Interpace Biosciences' Return on Sales [ROS] was 11.53% through Jun 30, 2026, down 1.06 percentage points year-over-year; for FY2025, it was 10.55%, down 6.73 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of +91.00 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was 17.28% in FY2024 (+7.40 pp), 9.88% in FY2023 (+21.24 pp), -11.36% in FY2022 (+7.77 pp) and -19.13% in FY2021 (+61.32 pp).
  • Quarterly Return on Sales [ROS] has moved between -25.88% (Q2 2022) and 21.86% (Q2 2024) over five years.
  • Compared with a year earlier, Return on Sales [ROS] was higher in five of the last eight quarters, with an average year-over-year change of -0.73 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2021 (a gain of 67.43 percentage points); the worst was Q2 2025 (a drop of 26.93 percentage points).
  • Per Business Quant data, IDXG's Return on Sales [ROS] in the three quarters before Q2 2026 was 12.43% (Q1 2026), 17.10% (Q4 2025) and 13.08% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 HCA Healthcare 105.29 Bn 103.13 Bn 17.03 Bn 15.00%
2 Natera 46.06 Bn 41.68 Bn 513.47 Mn -8.60%
3 Labcorp Holdings 30.09 Bn 28.19 Bn 1.11 Bn 10.55%
4 Quest Diagnostics 28.58 Bn 26.66 Bn 1.04 Bn 15.47%
5 Guardant Health 20.44 Bn 16.05 Bn 236.15 Mn -36.78%
6 BrightSpring Health Services 14.16 Bn 11.04 Bn 518.55 Mn 3.81%
7 Encompass Health 13.83 Bn 14.29 Bn 1.54 Bn 13.86%
8 Tempus AI 12.69 Bn 9.84 Bn 266.70 Mn -13.82%
9 Davita 11.06 Bn 9.92 Bn 1.13 Bn 13.95%
10 Interpace Biosciences 167.59 Mn 158.32 Mn 5.65 Mn 3.52%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.52%
Mar 31, 2026 12.43%
Dec 31, 2025 17.10%
Sep 30, 2025 13.08%
Jun 30, 2025 -5.07%
Mar 31, 2025 15.88%
Dec 31, 2024 16.61%
Sep 30, 2024 18.71%
Jun 30, 2024 21.86%
Mar 31, 2024 10.95%
Dec 31, 2023 14.71%
Sep 30, 2023 4.48%
Jun 30, 2023 11.01%
Mar 31, 2023 8.68%
Dec 31, 2022 0.65%
Sep 30, 2022 -9.52%
Jun 30, 2022 -25.88%
Mar 31, 2022 -12.33%
Dec 31, 2021 -14.84%
Sep 30, 2021 -22.65%
API Access

Interpace Biosciences Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IDXG&period=max&api_key=YOUR_API_KEY